-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Akebia Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2012 to 2023.
- Akebia Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $364K, a 8.54% decline year-over-year.
- Akebia Therapeutics, Inc. annual Depreciation for 2023 was $1.59M, a 4.17% decline from 2022.
- Akebia Therapeutics, Inc. annual Depreciation for 2022 was $1.65M, a 12.9% decline from 2021.
- Akebia Therapeutics, Inc. annual Depreciation for 2021 was $1.9M, a 9.52% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)